Neostigmine vs. sugammadex: on postoperative nausea and vomiting (PONV) after general anaesthesia
Sugammadex (SGM) is the first cyclodextrin derivative approved as an API, the result of a rational drug design, with a
Category: Pharma applications
Grafting of Cyclodextrin to Theranostic Nanoparticles Improves Blood-Brain Barrier Model Crossing
Core–shell superparamagnetic iron oxide nanoparticles hold great promise as a theranostic platform in biological systems. Herein, we report the biological
Inclusion complexation and liposomal encapsulation of an isoniazid hydrazone derivative in cyclodextrin for pH-dependent controlled release
Tuberculosis, a predominantly pulmonary pathology, is currently the deadliest infection worldwide. Its treatment is based on combination therapy involving selected
Special Issue entitled “The Role of Carbohydrate in Pharmaceuticals, Vaccines and Delivery Systems”
Special Issue entitled “The Role of Carbohydrate in Pharmaceuticals, Vaccines and Delivery Systems”, inPharmaceutics (*IF 6.525, 5-Year IF 7.227, PubMed,
Antibacterial drugs and cyclodextrin inclusion complexes: a patent review
The patents analyzed in the review used treatments based on antibiotics already on the market, natural products, and synthesized molecules
Nitric Oxide-Releasing Topological Supramolecular Nanocarriers with sliding CD units against MRSA
Polymeric systems that provide cationic charges or biocide-release therapeutics are used to treat the bacteria-infected wound. However, most antibacterial polymers
Antimicrobial and Antibiofilm Photodynamic Action of Photosensitizing Nanoassemblies Based on Sulfobutylether-β-Cyclodextrin
Developing new broad-spectrum antimicrobial strategies, as alternatives to antibiotics and being able to efficiently inactivate pathogens without inducing resistance, is
Review on cyclodextrin encapsulation and inteligent response for the release of curcumin
To overcome the low water solubility and low bioavailability of curcumin (CUR), multiple delivery strategies have been proposed. Among these,
Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer
Chemotherapy is the most used method after surgery in the treatment of colon cancer. Cancer cells escape the recognition mechanism
Oculis goes public on the Nasdaq Stock Market
Oculis the Icelandic (now global) ophthalmology company, founded by Thorsteinn Loftsson and Einar Stefánsson, celebrated its public listing on the